Acquired hepatocerebral degeneration and hepatic encephalopathy: one or two entities?

2020 ◽  
Vol 27 (12) ◽  
pp. 2396-2404 ◽  
Author(s):  
M. J. Malaquias ◽  
C. M. Pinto ◽  
C. Ramos ◽  
S. Ferreira ◽  
J. Gandara ◽  
...  
2002 ◽  
Vol 6 (3) ◽  
pp. 34-35
Author(s):  
B. J. Sher ◽  
Ian C. Duncan

Acquired hepatocerebral degeneration is a subtype of chronic recurrent hepatic encephalopathy and is characterised by movement disorders and increased signal intensity in the basal ganglia on Tl-weighted MRI images.


2011 ◽  
Vol 69 (3) ◽  
pp. 496-501 ◽  
Author(s):  
Fernando G. Romeiro ◽  
Madileine F. Américo ◽  
Fábio S. Yamashiro ◽  
Carlos A. Caramori ◽  
Arthur O. Schelp ◽  
...  

Acquired hepatocerebral degeneration (AHD) and hepatolenticular degeneration can have similar clinical presentations, but when a chronic liver disease and atypical motor findings coexist, the distinction between AHD and hepatic encephalopathy (HE) can be even more complicated. We describe three cases of AHD (two having HE) with different neuroimaging findings, distinct hepatic diseases and similar motor presentations, all presenting chronic arterial hypertension and weight loss before the disease manifestations. The diagnosis and physiopathology are commented upon and compared with previous reports. In conclusion, there are many correlations among HE, hepatolenticular degeneration and AHD, but the overlapping of AHD and HE could be more common depending on the clinical knowledge and diagnostic criteria adopted for each condition. Since AHD is not considered a priority that affects the liver transplant list, the prognosis in AHD patients remains poor, and flow interruption in portosystemic shunts must always be taken into account.


2015 ◽  
Author(s):  
Ronald F. Pfeiffer

Contrary to what one may assume, neurology and gastroenterology are similar to each other in many ways. A process found in one system can also affect the other, whether it be gastrointestinal (GI) dysfunction present in neurologic diseases or neurologic dysfunction present in GI diseases. Several disorders from both fields of medicines are highlighted in this review, ranging from stroke, Parkinson disease, and multiple sclerosis (MS) as examples of GI dysfunction in neurologic disease, to celiac disease and inflammatory bowel disease as examples of neurologic dysfunction in GI disease. Rare disorders such as Whipple disease (WhD), chronic acquired hepatocerebral degeneration (CAHD), and Wilson disease (WD) should also be considered for their neurologic dysfunctions as manifested extraintestinally. Tables give an overview of clinical features of the various disorders presented in this review.   This module contains ­4 highly rendered figures, 9 tables, 349 references, and 5 MCQs. 


2019 ◽  
Vol 15 (1) ◽  
pp. 128 ◽  
Author(s):  
Giovanni Caranci ◽  
Christian Cordano ◽  
Edoardo Giannini ◽  
Fabio Bandini

2009 ◽  
Vol 104 ◽  
pp. S295-S296
Author(s):  
Vishal Ghevariya ◽  
Fred Fallick ◽  
Manpreet Singh ◽  
Sury Anand

Sign in / Sign up

Export Citation Format

Share Document